International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group
about
Curing metastatic testicular cancerHow to calculate the dose of chemotherapyTesticular cancer: a prototypic tumor of young adultsImpact of Non-Pulmonary Visceral Metastases in the Prognosis and Practice of Metastatic Testicular Germ Cell TumorsSaudi Oncology Society and Saudi Urology Association combined clinical management guidelines for testicular germ cell tumorsCirculating tumor cells in germ cell tumors: are those biomarkers of real prognostic value? A reviewAdvances in the treatment of testicular cancerPediatric and Adolescent Extracranial Germ Cell Tumors: The Road to CollaborationA critical review of the analytical approaches for circulating tumor biomarker kinetics during treatmentPET/CT in paediatric malignancies - An updateThe Danish Testicular Cancer databaseRole of DNA repair machinery and p53 in the testicular germ cell cancer: a reviewThe two most common histological subtypes of malignant germ cell tumour are distinguished by global microRNA profiles, associated with differential transcription factor expressionPaclitaxel, ifosfamide, and cisplatin (TIP) as salvage and consolidation chemotherapy for advanced germ cell tumor.Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data.Cross platform analysis of methylation, miRNA and stem cell gene expression data in germ cell tumors highlights characteristic differences by tumor histology.Brain Metastases as Presenting Feature in 'Burned Out' Testicular Germ Cell Tumor.A decision-analytic approach to define poor prognosis patients: a case study for non-seminomatous germ cell cancer patientsA 20% dose reduction of the original CISCA/VB regimen allows better tolerance and similar survival rate in disseminated testicular non-seminomatous germ-cell tumors: final results of a phase III randomized trial.Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.Treatment-induced anaemia and its potential clinical impact in patients receiving sequential high dose chemotherapy for metastatic testicular cancerClinical and genetic aspects of testicular germ cell tumours.Intensive induction chemotherapy with C-BOP/BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948).Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminoma.Testicular cancer: seminomaOrchitis reveals an extragonadal primary mediastinal thymic seminoma: a coincidence or not?Risk stratification for venous thromboembolism in patients with testicular germ cell tumors.Prognostic role of programmed-death ligand 1 (PD-L1) expressing tumor infiltrating lymphocytes in testicular germ cell tumors.Circulating cell-free methylated DNA and lactate dehydrogenase release in colorectal cancerMechanisms of drug resistance in chemotherapy for urogenital carcinoma.Canadian consensus guidelines for the management of testicular germ cell cancer.Staging and prognostic factors in testicular cancer.Surgery versus surveillance in stage I non-seminoma testicular cancer.Management of testicular seminoma.A prospective study of cognitive function in men with non-seminomatous germ cell tumors.Regular review: Managing testicular cancerPrimary yolk sac tumor of the retroperitoneum: A case report and review of the literature.The bromodomain inhibitor JQ1 triggers growth arrest and apoptosis in testicular germ cell tumours in vitro and in vivo.Safety and efficacy of resistance training in germ cell cancer patients undergoing chemotherapy: a randomized controlled trial.Prognostic features and markers for testicular cancer management.
P2860
Q24536158-DA664540-343C-49EA-80EC-3BF867F8005DQ24642872-25825B6C-19E0-4A6C-99DA-0C9429C047C8Q24655649-BCA65B19-A442-4787-BD58-6D9D0A38DF63Q26740605-F8EA9C92-ED93-410B-91A4-4F79B553F931Q26747761-6A89106D-C4D2-4F1B-B4BB-660425C76681Q26752116-67D5D84F-6B42-4ACC-B239-1650B5FB3F98Q26773626-BF988245-960F-474B-A6A6-4DDE5E9884CBQ26797518-ADBBF8A2-5BE6-41DD-97B0-62652C61A704Q26862558-DD5D4798-1BD6-4FF3-B729-05A0BE4338D1Q28066175-3C91D47B-99BA-443A-8E76-D5F4D76ECCBCQ28069310-7AB9F59E-8AAE-49B0-B56C-43FA67FCB721Q28069963-96F03899-291F-49FF-82E8-8EA78C1F1A61Q28384874-C24E5264-0EF3-465E-8D22-56F1B5EF3AF2Q30421124-B083AA4F-2CAC-4DE1-B21D-13ADB479567EQ30557877-384C301D-3AD7-4BEA-81D6-B6E28A992C0CQ31010344-8F9571E5-DCB9-47F1-9B9B-5ADFA3F54D7AQ31096279-D541813B-F271-419B-8F3A-179E4031F2EDQ33313043-AA04BF88-00E8-4811-8F8F-7B331484A463Q33341214-FB5F45C7-2CB7-4015-A1E7-2EFBB15DDB05Q33343001-F216B89E-C2AB-43FD-9973-7CA97C09EF6EQ33344979-0473702E-9C32-4CA8-9CD2-D867CC164DDAQ33347763-B7757273-84FD-4CA2-B841-B68EF8AAB8EFQ33369071-7A6728EB-1E14-4AFD-B62D-1B2759814A33Q33403094-2409D2B9-A791-42A0-A08E-A62B63DFA5CBQ33448006-5C8622E7-EB3E-4E82-9482-CD4B00D9C807Q33560580-D60ED0A6-5A30-4096-A245-2D86FDDE0BDDQ33590396-3FC8DCAC-30EA-4C69-BFDD-32FBC3A1C57FQ33591683-00FC4EB3-70D6-40FA-BD73-2584E75DB5D2Q33611481-4EACB83D-9D3A-4F47-894D-DD9441A0AA10Q33746351-8F378F75-D489-4705-AD9F-91F6F8BD4819Q33753786-99A639EE-90A9-4B3F-88EA-ADDB74FD267BQ33788888-DA00127F-8A40-40FD-AC78-FE0617013A3AQ33788894-C2A0B067-D4E2-486C-AF3F-510626C0A289Q33788899-B50BAD6B-B2E4-4577-8A0D-EA8EE1DD1CC5Q33790550-61B9655B-8038-4CA2-A593-EC181A876737Q33806081-9D1A0389-79E5-4E2F-9AE2-8A93FAA74B35Q33844189-151B53D2-193F-4C25-BB51-915C9BA946E1Q33844624-99259413-2A30-47B2-B11B-5CA05CC89530Q33877463-16180256-1292-4020-A394-B5D4A4B3E825Q33884885-DFF05D26-F22B-4D4C-A334-804C05B64DC0
P2860
International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group
description
im Februar 1997 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 1997
@uk
name
International Germ Cell Consen ...... ell Cancer Collaborative Group
@en
International Germ Cell Consen ...... ell Cancer Collaborative Group
@nl
type
label
International Germ Cell Consen ...... ell Cancer Collaborative Group
@en
International Germ Cell Consen ...... ell Cancer Collaborative Group
@nl
prefLabel
International Germ Cell Consen ...... ell Cancer Collaborative Group
@en
International Germ Cell Consen ...... ell Cancer Collaborative Group
@nl
P1476
International Germ Cell Consen ...... ell Cancer Collaborative Group
@en
P304
P356
10.1200/JCO.1997.15.2.594
P407
P577
1997-02-01T00:00:00Z